MYCOF
Price:
$0.006
Market Cap:
$220.61K
Mydecine Innovations Group Inc., a biotech and life sciences company, engages in the development and commercialization of drugs for treating mental health problems. It develops therapies for veterans, emergency medical service providers, post-traumatic stress disorder, and front-line workers; and operates Mindleap, a digital telehealth platform that provides access to mental health services, as well as psychedelic integration services, including psychedelic aftercare and wellness services. The company also engages in the drug discovery and builds nature-sourced psychedelic-assisted therapeutics, compounds, therapy protocols, and unique delivery systems. In addition, it operates hemp farm in ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-01-08
Stock Exchange
PNK
Ticker
MYCOF
According to Mydecine Innovations Group Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.05. This represents a change of -55.62% compared to the average of -0.11 of the last 4 quarters.
The mean historical PE Ratio of Mydecine Innovations Group Inc. over the last ten years is -1.57. The current -0.05 PE Ratio has changed 219.39% with respect to the historical average. Over the past ten years (40 quarters), MYCOF's PE Ratio was at its highest in in the December 2022 quarter at 5.78. The PE Ratio was at its lowest in in the December 2014 quarter at -7.83.
Average
-1.57
Median
-0.99
Minimum
-7.68
Maximum
-0.02
Discovering the peaks and valleys of Mydecine Innovations Group Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.77%
Maximum Annual PE Ratio = -0.02
Minimum Annual Increase = -98.77%
Minimum Annual PE Ratio = -7.68
Year | PE Ratio | Change |
---|---|---|
2023 | -0.03 | -93.20% |
2022 | -0.42 | 1.77% |
2021 | -0.02 | -98.77% |
2020 | -1.84 | 106.61% |
2019 | -0.89 | -17.36% |
2018 | -1.08 | -51.78% |
2017 | -2.24 | 100.17% |
2016 | -1.12 | 243.50% |
2015 | -0.33 | -95.76% |
2014 | -7.68 | -17.22% |
The current PE Ratio of Mydecine Innovations Group Inc. (MYCOF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.16
5-year avg
-0.64
10-year avg
-1.57
Mydecine Innovations Group Inc.’s PE Ratio is less than Green Cures & Botanical Distribution Inc. (1.21), less than Cann American Corp. (0.46), greater than Rimrock Gold Corp. (-35.51), greater than Galexxy Holdings, Inc. (-3.66), greater than Indoor Harvest Corp (-0.12), greater than CBD Global Sciences Inc. (-0.28), greater than MGC Pharmaceuticals Limited (-0.55), greater than Target Group Inc. (-21.69), greater than Aequus Pharmaceuticals Inc. (-0.54), greater than Filament Health Corp. (-2.82), greater than Aleafia Health Inc. (-0.32), greater than Pharmagreen Biotech Inc. (-4.11), greater than Endexx Corporation (-1.42), less than Green Growth Brands Inc. (-0.00), less than HempAmericana, Inc (0), less than Radient Technologies Inc. (0), less than Nextleaf Solutions Ltd. (0), greater than Abattis Bioceuticals Corp. (-14.65), less than null (-0.02),
Company | PE Ratio | Market cap |
---|---|---|
1.21 | $522.63K | |
0.46 | $4.21M | |
-35.51 | $312.30K | |
-3.66 | $5.83M | |
-0.12 | $320.57K | |
-0.28 | $2.07M | |
-0.55 | $12.11M | |
-21.69 | $1.48M | |
-0.54 | $1.11M | |
-2.82 | $10.58M | |
-0.32 | $6.09M | |
-4.11 | $1.66M | |
-1.42 | $6.01M | |
-0.00 | $2.06K | |
0 | $302.60K | |
0 | $19.27M | |
0 | $8.56M | |
-14.65 | $47.60K | |
-0.02 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mydecine Innovations Group Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Mydecine Innovations Group Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Mydecine Innovations Group Inc.'s PE Ratio?
How is the PE Ratio calculated for Mydecine Innovations Group Inc. (MYCOF)?
What is the highest PE Ratio for Mydecine Innovations Group Inc. (MYCOF)?
What is the 3-year average PE Ratio for Mydecine Innovations Group Inc. (MYCOF)?
What is the 5-year average PE Ratio for Mydecine Innovations Group Inc. (MYCOF)?
How does the current PE Ratio for Mydecine Innovations Group Inc. (MYCOF) compare to its historical average?